[Various effects of monoamine oxidase inhibitors under conditions of complete monoamine oxidase inhibition on the serotonin, dopamine and noradrenaline levels in the rat brain].
D000818:Animals; D001921:Brain / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D005470:Fluorometry; D009638:Norepinephrine / Q000378:metabolism*; D010624:Phenelzine / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism*; D014191:Tranylcypromine / Q000494:pharmacology*
D012701:Serotonin; D014191:Tranylcypromine; D012110:Reserpine; D010624:Phenelzine; D004298:Dopamine; D009638:Norepinephrine
Unterschiedliche Wirkungen von Monoaminoxydase-Hemmern unter den Bedingungen vollständiger Monoaminoxydase-Hemmung auf den Serotonin-, Dopamin- und Noradrenalin-Gehalt des Rattenhirns.